Construction of Pfizer-sponsored pharmaceutical factory starts in Russia
31 May 2017
A ground-breaking ceremony of a pharmaceutical factory was held on Tuesday in Vorsino technology park located near the Russian city of Kaluga. American company Pfizer is an investor of the enterprise's building project.
According to TASS news agency, the main partner of the project is NovaMedica, a portfolio company of the Russian government-owned company Rusnano engaged in the development of nanotechnology.
Speaking at the ceremony, Chairman of Rusnano’s Board Anatoly Chubais said that NovaMedica has barely started the construction of its factory, but it is already having the sales volume amounting to 1 billion rubles on the Russian market.
A third of medical drugs that will be manufactured at the enterprise under a license of Pfizer are not currently produced in the territory of Russia.
PrintShareholders
Pipeline
Media Center
-
Engineered native gut bacteria shows promise to treat diabetes
08 August 2022
-
Pain drug stigma stops patients from getting meds but opioid side effects, fatalities muddy waters
08 August 2022
-
Pharmacopoeias to further support vaccine development and supply
05 August 2022
-
Global alliance to end childhood AIDS
05 August 2022